|Day Low/High||3.35 / 4.20|
|52 Wk Low/High||2.64 / 19.08|
Conference Call Today at 4:30 pm EST
- Breast Density and Mammography Reporting Act of 2017 -
Stocks with insider trader activity include ATOS, EGLT and VRNS
Atossa Genetics (ATOS) shares are up over 20% after announcing that the FDA accepted its Investigational New Drug Application for Fulvestrant.
Keep these under-$10 stocks on your breakout trading radar.
Atossa Genetics (ATOS) shares are rising after the company received a patent for its breast cancer detecting absorbent paper.
Trade-Ideas LLC identified Atossa Genetics (ATOS) as a strong on high relative volume candidate
Keep these under-$10 biotech stocks on your breakout trading radar.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.